Bilgen Başgut (Bilgen Basgut)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Multidrug Resistant

Chronic Kidney Disease

Helicobacter Pylori Infection

Prognostic Factors

Top Venues

BMC pharmacology & toxicology

Antibiotics (Basel, Switzerland)

Journal of chemotherapy (Florence, Italy)

European journal of hospital pharmacy : science and practice

This page only lists publications with an associated author ORCID identifier.

Publications

Aysel Pehlivanlı, Sayeste Akkan Eren, Şule Şengül, Bilgen Başgut, Sehsuvar Erturk, A Tanju Ozcelikay
Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital. BMC pharmacology & toxicology 25 (1) (2024)
Aysel Pehlivanlı, Sayeste Akkan Eren, Şule Şengül, Bilgen Başgut, Sehsuvar Erturk, A Tanju Ozcelikay
Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital. BMC pharmacology & toxicology 25 (1) (2024)
Aysel Pehlivanlı, Tuğba Y Yalçın, Fatma İrem Yeşiler, Helin Şahintürk, Özlem K Azap, Pınar Zeyneloğlu, Bilgen Başgut
Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different doses. Journal of chemotherapy (Florence, Italy) (2024)
Al Maamon R Abu Jaber, Bilgen Başgut, Ali Abdullah Hawan, Ali Amer Al Shehri, Sultan Ahmad AlKahtani, Nehad Jaser Ahmed, Abdikarim Mohamed Abdi
The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Aysel Pehlivanlı, Cigdem Ozgun, Firdevs Gonca Sasal-Solmaz, Didem Yuksel, Bilgen Başgut, Arif Tanju Ozcelikay, Mustafa Necmettin Unal
An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalation. European journal of hospital pharmacy : science and practice (2024)
Aysel Pehlivanlı, Sayeste Akkan Eren, Şule Şengül, Bilgen Başgut, Sehsuvar Erturk, A Tanju Ozcelikay
Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital. BMC pharmacology & toxicology 25 (1) (2024)
Aysel Pehlivanlı, Sayeste Akkan Eren, Şule Şengül, Bilgen Başgut, Sehsuvar Erturk, A Tanju Ozcelikay
Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital. BMC pharmacology & toxicology 25 (1) (2024)
Al Maamon R Abu Jaber, Bilgen Başgut, Ali Abdullah Hawan, Ali Amer Al Shehri, Sultan Ahmad AlKahtani, Nehad Jaser Ahmed, Abdikarim Mohamed Abdi
The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Aysel Pehlivanlı, Sayeste Akkan Eren, Şule Şengül, Bilgen Başgut, Sehsuvar Erturk, A Tanju Ozcelikay
Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital. BMC pharmacology & toxicology 25 (1) (2024)
Aysel Pehlivanlı, Sayeste Akkan Eren, Şule Şengül, Bilgen Başgut, Sehsuvar Erturk, A Tanju Ozcelikay
Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital. BMC pharmacology & toxicology 25 (1) (2024)
Aslınur Albayrak, Hasan Selçuk Özger, Bilgen Başgut, Şahender Gülbin Aygencel Bıkmaz, Bensu Karahilal
Impact of clinical pharmacist's interventions on clinical outcomes in appropriate use of colistin: a prospective pre-post intervention study. Journal of chemotherapy (Florence, Italy) (2023)